We are Sorry, This Page doesn't Exist

The ancillary cannabis company Hydrofarm Holdings Group, Inc. (NASDAQ: HYFM), announced Wednesday that it priced an underwritten public offering of 4.81 million of its shares at a price of $59 per share to collect roughly $269.3 million. read more.....»»

Akerna Corp (NASDAQ: KERN) is moving higher on Wednesady morning after business intelligence from the company showed that April 20 had the highest retail cannabis sales ever recorded.  read more.....»»

Organigram Holdings Inc. stock soars during extended trading, as the Canadian weed company reported fiscal first-quarter revenue that jumped two-fold, beating Wall Street estimates......»»

Progyny, a Manhattan fertility benefits management company, saw its shares surge on its first day of trading Friday on Nasdaq in a positive sign for tech-enabled health companies looking to go... To view the full story, click the title link......»»

Hexo Corp. shares fell sharply in Thursday trading after the company announced a sequential decline in revenue as part of its third-quarter earnings just months following recreational legalization of marijuana in Canada......»»

Quebec-based cannabis producer Hexo Corp.’s stock dropped 4% in Tuesday trading amid concerns about flooding near its production facility in Gatineau, Quebec, but the company said the facility was not at risk......»»

Video conferencing company Zoom Video Communications opened at $65 per share on Thursday, 80.6 percent above its initial public offering price, in its debut on the Nasdaq......»»

Tilray (NASDAQ: TLRY) shares were jumping in after-hours trading Monday after the Canadian cannabis company reported fiscal fourth-quarter and full-year financia.....»»

Tilray (NASDAQ: TLRY) shares were jumping in after-hours trading Monday after the Canadian cannabis company reported fiscal fourth-quarter and full-year financial results.  read more.....»»

Canadian cannabis company Tilray Inc (NASDAQ: TLRY) experienced a wild Wednesday trading session, which is clearly not a positive for the relatively investment new sector, according to Steve Ottaway. read more.....»»

FSD Pharma Inc. (OTC: FSDDF), a Canada-based licensed producer of marijuana, reached an agreement to acquire nano-cap company Therapix Biosciences ADR (NASDAQ: read more.....»»

Canadian cannabis producer Tilray Inc. (NASDAQ: TLRY) announced the formation of its International Advisory Board, which will provide guidance to the company's executive team and board of directors. read more.....»»

Canadian cannabis producer Aurora Cannabis Inc (NYSE: ACB)'s shares were trading lower Tuesday after the company issued below-consensus revenue guidance for the fiscal second quarter. read more.....»»

Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year read more.....»»

Shares of Red Robin Gourmet Burgers (NASDAQ:RRGB) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 95.50% over the past year to ($0.30), which beat the estimate of ($1.16). read more.....»»

Shares of Zscaler (NASDAQ:ZS) rose in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased 114.29% year over year to $0.15, which beat the estimate of $0.07. read more.....»»

Shares of Capital Southwest (NASDAQ:CSWC) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 5.41% over the past year to $0.39, which missed the estimate of $0.43. read more.....»»

Pieris Pharmaceuticals Inc (NASDAQ: PIRS) shares are trading higher by 57% at $2.91 after the company announced a respiratory and ophthalmology collaboration with Genentech. read more.....»»

Shares of Nordson (NASDAQ:NDSN) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 34.18% year over year to $2.12, which beat the estimate of $1.64. read more.....»»

Scopus BioPharma (NASDAQ:SCPS) shares are trading higher after the company announced the FDA has approved its IND application for CpG-STAT3siRNA, the company's distinctive immuno-oncology RNA therapy for the treatment of multiple cancers. read more.....»»